LENZ THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.80 USD | -0.34% |
|
+1.75% | 0.00% |
Chart calendar LENZ Therapeutics, Inc.
ce592bbf55781f59d305535d722e98c.vt4rVhXJ8YXKuMTX5dQf7hc4wg7ttASG5oW46HjrDy4.z4dqNEyAkLKl7K2arrh4n019o0uI5VH20f3npA2YfXbG70BhXby99r_8ow~64949bb868282b34584861c69ba4e0eb
Upcoming events on LENZ Therapeutics, Inc.
Past events on LENZ Therapeutics, Inc.
| 05/09/2024 | Wells Fargo Healthcare Conference - One on One |
| 04/09/2024 | Morgan Stanley Healthcare Conference - One On One |
| 15/08/2024 | H.C. Wainwright Ophthalmology Virtual Conference |
| 15/08/2024 02:00 am | Q2 2024 Earnings Call |
| 15/08/2024 01:35 am | Q2 2024 Earnings Release |
| 18/06/2024 05:30 pm | Investor Meeting - Key Opinion Leader |
| 06/06/2024 11:30 pm | Jefferies Global Healthcare Conference |
| 09/05/2024 02:00 am | Q1 2024 Earnings Call |
| 09/05/2024 01:31 am | Q1 2024 Earnings Release |
| 03/04/2024 05:30 pm | CLARITY Phase 3 Study Results Call |
Past dividends on LENZ Therapeutics, Inc.
| 22/03/2024 | 1.03 USD |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 | 6,82 | 54,7 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -57,0 | -70,7 | -73,2 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -59,4 | -74,7 | -60,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -54,4 | -78,1 | -51,7 |
|
Net income Million USD | Released Forecast Spread | -70,0 | -53,3 | -70,9 | -60,2 |
|
EPS USD | Released Forecast Spread | -7,22 | -2,81 | -2,45 | -2,08 |
| Announcement Date | 22/03/24 | - |
Quarterly results
| Fiscal Period | June | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 5,35 | 7,40 |
|
EBITDA Million USD | Released Forecast Spread | -16,1 -18,1 11.16% | -14,3 -16,1 11.12% | -13,3 | -13,4 | ||||
|
EBIT Million USD | Released Forecast Spread | -16,1 -17,0 5.5% | -14,4 -14,6 1.5% | -14,1 | -14,8 | -15,0 | -19,0 | -13,0 | -23,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,6 -16,2 -2.62% | -10,3 -11,6 11.56% | -13,2 | -14,3 | -13,7 | -17,8 | -11,9 | -22,9 |
|
Net income Million USD | Released Forecast Spread | -16,6 -15,4 -8.16% | -10,3 -12,2 15.84% | -12,8 | -13,6 | -13,7 | -17,8 | -11,9 | -22,9 |
|
EPS USD | Released Forecast Spread | -3,53 -0,82 -330.82% | -0,40 -0,48 16.33% | -0,47 | -0,49 | -0,52 | -0,72 | -0,76 | -0,78 |
| Announcement Date | 08/05/24 | 14/08/24 | - | - | - | - | - | - |
More events
Past sector events for LENZ Therapeutics, Inc.
| 05/09/2024 01:50 pm | PHARMAESSENTIA CORPORATION: August 2024 Sales and Revenue Release |
| 04/09/2024 01:31 am | ASCENDIS PHARMA A/S: Q2 2024 Earnings Release |
| 03/09/2024 04:35 pm | GH RESEARCH PLC: Q2 2024 Earnings Release |
| 28/08/2024 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q2 2024 Earnings Release (Projected) |
| 28/08/2024 | AKESO, INC.: Q2 2024 Earnings Release |
| 27/08/2024 06:40 pm | KEYMED BIOSCIENCES INC.: Q2 2024 Earnings Release |
| 27/08/2024 | BEIGENE, LTD.: Q2 2024 Earnings Release |
| 26/08/2024 | HITGEN INC.: Q2 2024 Earnings Release (Projected) |
| 23/08/2024 06:20 am | CLARITY PHARMACEUTICALS LTD: Q4 2024 Earnings Release |
| 23/08/2024 | DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q2 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LENZ Stock
- Calendar LENZ Therapeutics, Inc.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition